ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex

Spread the love

–News Direct–

ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band 2.0 FLEX by the U.S. Food and Drug Administration.

Hickey told Proactive this FDA approval represents a historic event for ReShape Lifesciences and is expected to serve as a pivotal driver of growth for the company's Lap-Band franchise. The development of the enhanced Lap-Band 2.0 FLEX was led by physicians with a primary focus on improving the overall patient experience.

This FDA approval marks a significant milestone for ReShape Lifesciences, highlighting the company's commitment to advancing patient-centered innovations in the field of medical devices.

Contact Details

Proactive USA

+1 347-449-0879

[email protected]

View source version on

ReShape Lifesciences Inc

comtex tracking


Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Biz Power News journalist was involved in the writing and production of this article.

Cloud PR Wire